Mersana Therapeutics earnings were -$74.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest MRSN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$24.1M, up 70.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MRSN reported annual earnings of -$69.2M, with -59.7% growth.
Mersana Therapeutics Earnings Reports & History FAQ
What were Mersana Therapeutics's earnings last quarter?
On MRSN's earnings call on Invalid Date, Mersana Therapeutics (NASDAQ: MRSN) reported Q1 2025 earnings per share (EPS) of -$0.19, up 18.75% year over year. Total MRSN earnings for the quarter were -$24.12 million. In the same quarter last year, Mersana Therapeutics's earnings per share (EPS) was -$0.16.
Is Mersana Therapeutics profitable or losing money?
As of the last Mersana Therapeutics earnings report, Mersana Therapeutics is currently losing money. Mersana Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$74.01 million, a 45.1% decrease year over year.
What was MRSN's earnings growth in the past year?
As of Mersana Therapeutics's earnings date in Invalid Date, Mersana Therapeutics's earnings has grown year over year. MRSN earnings in the past year totalled -$74.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.